Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Acasti Pharma Inc. | Director | Common Shares | 370K | $684K | $1.85 | Oct 10, 2023 | Direct |
Acasti Pharma Inc. | Director | Common Shares | 124K | $230K | $1.85 | Oct 10, 2023 | By Kottayil Grace Pharma LLC |
Acasti Pharma Inc. | Director | Stock Options (Right to Buy) | 22.5K | Dec 19, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACST | Acasti Pharma Inc. | Dec 19, 2023 | 1 | $0 | 4 | Dec 20, 2023 | Director |
ACST | Acasti Pharma Inc. | Oct 10, 2023 | 0 | $0 | 3 | Oct 20, 2023 | Director |
ACST | Acasti Pharma Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 23, 2022 | COO, US |
ACST | Acasti Pharma Inc. | Nov 10, 2021 | 0 | $0 | 3 | Nov 23, 2021 | COO, US |